Differential toxicities of albendazole and its two main metabolites to Balb/c 3T3, HepG2, and FaO lines and rat hepatocytes

1. Baliharová V., Skálova L., Maas R.F.M., De Vrieze G., Bull S., Fink-Gremmels J.: The effects of benzimidazole anthelmintics on P4501A in rat hepatocytes and HepG2 cells. Res Vet Sci 2003, 75, 61-69.10.1016/S0034-5288(03)00033-XSearch in Google Scholar

2. Blaauboer B.J., Boobis A.R., Castell J.V., Coecke S., Groothuis G.M.M., Guillouzo A., Hall T.J., Hawksworth G.M. Lorenzon G., Miltenburger H.G., Rogiers V., Skett P., Viia P., Wiebel F.J.: The practical applicability of hepatocyte cultures in routine testing. ECVAM Workshop Report 1. ATLA 1994, 22, 231-241.10.1177/026119299402200404Search in Google Scholar

3. Borenfreund E., Puerner J.A.: Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985, 24, 119-124.10.1016/0378-4274(85)90046-3Search in Google Scholar

4. Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of dye binding. Anal Biochem 1976, 72, 248-254.10.1016/0003-2697(76)90527-3Search in Google Scholar

5. Campbell W.C.: Benzimidazoles: veterinary uses. Parasitol Today 1990, 6, 130-133.10.1016/0169-4758(90)90231-RSearch in Google Scholar

6. Capleton A.C., Courage C., Rumsby P., Holmes P., Stutt E., Boxall A.B.A., Levy L.S.: Prioritising veterinary medicines according to their potential indirect human exposure and toxicity profile. Toxicol Lett 2006, 163, 213-223.10.1016/j.toxlet.2005.10.02316513297Search in Google Scholar

7. Carlsson G., Patring J., Ulleras E., Oskarsson A.: Developmental toxicity of albendazole and its three main metabolites in zebrafish embryos. Reprod Toxicol 2011, 32, 129-137.10.1016/j.reprotox.2011.05.01521683134Search in Google Scholar

8. Cristòfol C., Navarro M., Franquelo C., Valladares J.E., Carretero A., Ruberte J., Arboix M.: Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: developmental toxicity. Toxicol Appl Pharmacol 1997, 144, 56-61.10.1006/taap.1997.81149169069Search in Google Scholar

9. Delatour P. Some aspects of the teratogenicity of veterinary drugs. Vet Res Commun 1983, 7, 125-131.10.1007/BF022286066665979Search in Google Scholar

10. Donato M.T., Lahoz A., Castell J.V., Gómez-Lechón M.J.: Cell lines: a tool for in vitro drug metabolism studies. Curr Drug Metab 2008, 9, 1-11.10.2174/13892000878333108618220566Search in Google Scholar

11. Donato M.T., Jover R., Gómez- Lechón M. J.: Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering. Curr Drug Metab 2013, 14, 946-968.10.2174/1389200211314090002Search in Google Scholar

12. Eckardt K., Kaltenhauser J., Kilb C., Seiler A., Stahlmann R.: Relative potency of albendazole and its sulfoxide metabolite in two in vitro tests for developmental toxicity: the rat whole embryo culture and the mouse embryonic stem cell test. Reprod Toxicol 2012, 34, 378-384.10.1016/j.reprotox.2012.05.037Search in Google Scholar

13. European Medicines Agency (EMEA). 2004. Committee for medicinal products for veterinary use. Albendazole - Summary Report (3). Available from: http://www.emea.eu.int.Search in Google Scholar

14. Fotakis G., Timbrell J.A.: In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006, 160, 171-177.10.1016/j.toxlet.2005.07.001Search in Google Scholar

15. Gerets H.H.J., Hanon E., Cornet M., Dhalluin S., Depelchin O., Canning M., Atienzar F.A.: Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach. Toxicol in Vitro 2009, 23, 319-332.10.1016/j.tiv.2008.11.012Search in Google Scholar

16. Ivanova L., Uhlig S.: A bioassay for the simultaneous measurement of metabolic activity, membrane integrity, and lysosomal activity in cell cultures. Anal Biochem 2008, 379, 16-19.10.1016/j.ab.2008.04.035Search in Google Scholar

17. Korzeniewski C., Calleawert D.M.: An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983, 64, 313-320.10.1016/0022-1759(83)90438-6Search in Google Scholar

18. Mattsson A., Ulleras E., Patring J., Oskarsson A.: Albendazole causes stage-dependent developmental toxicity and is deactivated by mammalian metabolization system in a modified zebrafish embryotoxicity test. Reprod Toxicol 2012, 34, 31-42.10.1016/j.reprotox.2012.02.007Search in Google Scholar

19. Martin R.J.: Models of action of anthelmintic drugs. Vet J 1997, 154, 11-34.10.1016/S1090-0233(05)80005-XSearch in Google Scholar

20. Pohjala L., Tammela P., Samanta S.K., Yli-Kauhaluoma J., Vuorela P.: Assessing the data quality in predictive toxicology using a panel of cell lines and cytotoxicity assays. Anal Biochem 2007, 362, 221-228.10.1016/j.ab.2006.12.038Search in Google Scholar

21. Pourgholami M.H., Woon L., Almajd R., Akhter J., Bowery P., Morris D.L.: In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett 2001, 165, 43-49.10.1016/S0304-3835(01)00382-2Search in Google Scholar

22. Rico A.G., Burgat-Sacaze V.: Veterinary drugs and food safety: a toxicological approach. Rev sci tech Off int Epiz 1985, 4, 111-119.10.20506/rst.4.1.188Search in Google Scholar

23. Rolin S., Souhaili-ei Amri H., Batt A.M., Levy M., Baqrel D., Siest G.: Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines. Cell Biol Toxicol 1989, 5, 1-14.10.1007/BF00141060Search in Google Scholar

24. Scheers E.M., Ekwall B., Dierickx P.J.: In vitro long-term cytotoxicity testing of 27 MEIC chemicals on HepG2 cells and comparison with acute human toxicity data. Toxicol in Vitro 2001, 15, 153-161.10.1016/S0887-2333(00)00062-XSearch in Google Scholar

25. Seglen P.O.: Preparation of isolation rat liver cells. Methods Cells Biol 1976, 13, 29-83.10.1016/S0091-679X(08)61797-5Search in Google Scholar

26. Wang K., Shindoh H., Inoue T., Horii I.: Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell line. J Toxicol Sci 2002, 27, 229-237.10.2131/jts.27.229Search in Google Scholar

27. Weyermenn J., Lohmann D., Zimmer A.: A practical note on the use of cytotoxicity assays. Int J Pharm 2005, 288, 369-376.10.1016/j.ijpharm.2004.09.018Search in Google Scholar

28. Whittaker S.G., Faustman E.M.: Effects of albendazole and albendazole sufoxide on cultures of differentiating rodent embryonic cells. Toxicol Appl Pharmacol 1991, 109, 73-84.10.1016/0041-008X(91)90192-HSearch in Google Scholar

29. Wilk-Zasadna I., Bernasconi C., Pelkonen O., Coecke S.: Biotransformation in vitro: an essential consideration in the quantitative in vitro-to-in vivo extrapolation (QIVIVE) of toxicity data. Toxicology 2015, 332, 8-19.10.1016/j.tox.2014.10.00625456264Search in Google Scholar